Product Name :
Nuclear and Cytoplasmic Extraction Kit Applications :
Nuclear and Cytoplasmic Extraction Background :
For research of cell protein, the separation of cytosol and nucleus protein attracted researchers’ attention. This requires effective reagents to separate cytoplasmic and nuclear extracts from cultured mammalian cells. The kit enables stepwise proteins: Reagent A disrupts cell membrane while not acts on nuclear. Reagent B lyses the nuclei. It is effective to separate cytoplasmic and nuclear proteins in short time with this kit. The extracts are suitable for WB, co-IP and purification of proteins. Due to the reagents in this kit, BCA Protein Assay method is recommended to quantify the protein concentrations of extracts. There are no protease inhibitors in this kit, prepare protease inhibitors before use. Alternative Name :
1) This kit is only used for mammalian cell. 2) Avoid freeze-thaw cycles. Recommend to aliquot before stored at -20℃ or -80℃.Period of validity is 12 months(-20℃); 3) This kit doesn’t contain protease inhibitors, prepare protease inhibitor before use. 4) Resuspend the precipitate with reagent B in the tube as you can as possible, but there might be flocculent fragments. That causes no impact on the nuclear extract. 5) All steps on ice. Classification :
WB Related Reagents Format :
Liquid Contents :
1) Reagent A: 50ml, stored at -20℃, recommend to aliquot before stored at -20℃. 2) Reagent B: 10ml, stored at -20℃, recommend to aliquot before stored at -20℃. Storage & Shelf Life :
A: stored at -20℃, recommend to aliquot before stored at -20℃. B: stored at -20℃, recommend to aliquot before stored at -20℃. Procedure :
1) For adherent mammalian cells(1-10*106 cells): the cells were harvested with trypsin-EDTA, the centrifuged at 500g for 3min, 4℃; For suspension mammalian cells(1-10*106 cells): the cells were centrifuged at 500g for 3min. Resuspend and wash the cells with PBS in a 1.5 ml tube. Then centrifuge the cells at 500g for 3min, remove and discard the supernatant as much as possible. 2) Add 800-1000µl reagent A (for 1-10*106 cells) with protease inhibitors to the precipitate; Resuspend the precipitate and vortex the tube for 15s. 3) Place the tube on ice for 20min. During this period, vortex the tube for 15s to resuspend the precipitate each 5min. 4) Centrifuge the tube at 3000g for 10min, 4℃. Transfer the supernatant (cytoplasmic extracts) to a new tube. Store at 4℃ (for short term) or -80℃ (for long term). 5) Add 500µl reagent A with protease inhibitors to the precipitate (left in the tube during step 4), resuspend and wash the precipitate. Centrifuge at 3000g for 10min. Remove and discard the supernatant. (May be omitted if you can almost transfer the cytoplasmic extracts completely in step 4.) 6) Add 150-200µl reagent B with protease inhibitors to the precipitate (left in the tube during step 4 or 5). Resuspend the precipitate and vortex the tube for 15s. Place the tube on ice for 10min. Then vortex the tube for 15s to resuspend the precipitate every 5min, for total 20min. 7) Centrifuge the tube at 12000g for 20min, 4℃. Transfer the supernatant (nuclear extract) to a new tube. Store at 4℃ (for short term) or -80℃ (for long term). Research use :
For research use only, not for use in diagnostic procedures. Expiration Date :
Period of validity is 12 months.
Nuclear and Cytoplasmic Extraction Kit Applications :
Nuclear and Cytoplasmic Extraction Background :
For research of cell protein, the separation of cytosol and nucleus protein attracted researchers’ attention. This requires effective reagents to separate cytoplasmic and nuclear extracts from cultured mammalian cells. The kit enables stepwise proteins: Reagent A disrupts cell membrane while not acts on nuclear. Reagent B lyses the nuclei. It is effective to separate cytoplasmic and nuclear proteins in short time with this kit. The extracts are suitable for WB, co-IP and purification of proteins. Due to the reagents in this kit, BCA Protein Assay method is recommended to quantify the protein concentrations of extracts. There are no protease inhibitors in this kit, prepare protease inhibitors before use. Alternative Name :
1) This kit is only used for mammalian cell. 2) Avoid freeze-thaw cycles. Recommend to aliquot before stored at -20℃ or -80℃.Period of validity is 12 months(-20℃); 3) This kit doesn’t contain protease inhibitors, prepare protease inhibitor before use. 4) Resuspend the precipitate with reagent B in the tube as you can as possible, but there might be flocculent fragments. That causes no impact on the nuclear extract. 5) All steps on ice. Classification :
WB Related Reagents Format :
Liquid Contents :
1) Reagent A: 50ml, stored at -20℃, recommend to aliquot before stored at -20℃. 2) Reagent B: 10ml, stored at -20℃, recommend to aliquot before stored at -20℃. Storage & Shelf Life :
A: stored at -20℃, recommend to aliquot before stored at -20℃. B: stored at -20℃, recommend to aliquot before stored at -20℃. Procedure :
1) For adherent mammalian cells(1-10*106 cells): the cells were harvested with trypsin-EDTA, the centrifuged at 500g for 3min, 4℃; For suspension mammalian cells(1-10*106 cells): the cells were centrifuged at 500g for 3min. Resuspend and wash the cells with PBS in a 1.5 ml tube. Then centrifuge the cells at 500g for 3min, remove and discard the supernatant as much as possible. 2) Add 800-1000µl reagent A (for 1-10*106 cells) with protease inhibitors to the precipitate; Resuspend the precipitate and vortex the tube for 15s. 3) Place the tube on ice for 20min. During this period, vortex the tube for 15s to resuspend the precipitate each 5min. 4) Centrifuge the tube at 3000g for 10min, 4℃. Transfer the supernatant (cytoplasmic extracts) to a new tube. Store at 4℃ (for short term) or -80℃ (for long term). 5) Add 500µl reagent A with protease inhibitors to the precipitate (left in the tube during step 4), resuspend and wash the precipitate. Centrifuge at 3000g for 10min. Remove and discard the supernatant. (May be omitted if you can almost transfer the cytoplasmic extracts completely in step 4.) 6) Add 150-200µl reagent B with protease inhibitors to the precipitate (left in the tube during step 4 or 5). Resuspend the precipitate and vortex the tube for 15s. Place the tube on ice for 10min. Then vortex the tube for 15s to resuspend the precipitate every 5min, for total 20min. 7) Centrifuge the tube at 12000g for 20min, 4℃. Transfer the supernatant (nuclear extract) to a new tube. Store at 4℃ (for short term) or -80℃ (for long term). Research use :
For research use only, not for use in diagnostic procedures. Expiration Date :
Period of validity is 12 months.
Canonical hedgehog signalling regulates hepatic stellate cell‐mediated angiogenesis in liver fibrosis
PMCID: Pubmed No.:28052321
Parthenolide reverses doxorubicin resistance in human lungcarcinoma A549 cells by attenuating NF- B activation and HSP70 up-regulation
PMCID: Pubmed No.:23792430
Tetrandrine Suppresses Lipopolysaccharide-Induced Microglial Activation by Inhibiting NF-κB and ERK Signaling Pathways in BV2 Cells
PMCID: Pubmed No.:25115855
Tetramethylpyrazine prevents ethanol-induced hepatocyte injury via activation of nuclear factor erythroid 2-related factor 2
PMCID: Pubmed No.:26341692
Quercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathway
PMCID: Pubmed No.:26643168
Anti-osteoclastogenic activity of isoliquiritigenin via inhibition of NF-κB-dependent autophagic pathway
PMCID: Pubmed No.:26947453
Tetrandrine Suppresses Lipopolysaccharide-Induced Microglial Activation by Inhibiting NF-κB and ERK Signaling Pathways in BV2 Cells
PMCID: Pubmed No.:25115855
Quercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathway
PMCID: Pubmed No.:26643168
Anti-osteoclastogenic activity of isoliquiritigenin via inhibition of NF-κB-dependent autophagic pathway
PMCID: Pubmed No.:26947453
Apigenin Attenuates Oxidative Injury in ARPE-19 Cells thorough Activation of Nrf2 Pathway
PMCID: Pubmed No.:27656262
Strategy of integrated evaluation on treatment of traditional Chinese medicine as ‘interaction of system to system’ and establishment of novel fuzzy target contribution recognition with herb-pairs, a case study on Astragali Radix-Fructus Corni
PMCID: Pubmed No.:27392498
Lysine-specific demethylase 1 mediates epidermal growth factor signaling to promote cell migration in ovarian cancer cells
PMCID: Pubmed No.:26489763
Regulation of angiogenic behaviors by oxytocin receptor through Gli1-indcued transcription of HIF-1α in human umbilical vein endothelial cells
PMCID: Pubmed No.:28445928
Curcumin regulates cell fate and metabolism by inhibiting hedgehog signaling in hepatic stellate cells
PMCID: Pubmed No.:25938627
Tetramethylpyrazine prevents ethanol-induced hepatocyte injury via activation of nuclear factor erythroid 2-related factor 2
PMCID: Pubmed No.:26341692
Inactivation of EGFR/AKT signaling enhances TSA-induced ovarian cancer cell differentiation
PMCID: Pubmed No.:28393191
Quercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathway
PMCID: Pubmed No.:26643168
Oligomeric proanthocyanidins protects A549 cells against H2O2-induced oxidative stress via the Nrf2-ARE pathway
PMCID: Pubmed No.:28487966
SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity
PMCID: Pubmed No.:31913745
Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α
PMCID: Pubmed No.:29344293
β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression
PMCID: Pubmed No.:32113150
β-elemonic acid inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells through the suppression of JAK2/STAT3/MCL-1 and NF-ĸB signal pathways
PMCID: Pubmed No.:33878321
A Solid Dispersion of Quercetin Shows Enhanced Nrf2 Activation and Protective Effects against Oxidative Injury in a Mouse Model of Dry Age-Related Macular Degeneration
PMCID: Pubmed No.:31781321
Apigenin Protects Mouse Retina against Oxidative Damage by Regulating the Nrf2 Pathway and Autophagy
PMCID: Pubmed No.:32509154
Pterostilbene attenuates RIPK3-dependent hepatocyte necroptosis in alcoholic liver disease via SIRT2-mediated NFATc4 deacetylation
PMCID: Pubmed No.:34474091
Inhibition of NF‐κB is required for oleanolic acid to downregulate PD‐L1 by promoting DNA demethylation in gastric cancer cells
PMCID: Pubmed No.:32894642
Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells
PMCID: Pubmed No.:31271843
Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells
PMCID: Pubmed No.:30103008
-Hederin Arrests Cell Cycle at G2/M Checkpoint and Promotes Mitochondrial Apoptosis by Blocking Nuclear Factor-B Signaling in Colon Cancer Cells
PMCID: Pubmed No.:30363706
Degradation of HIF-1α induced by curcumol blocks glutaminolysis and inhibits epithelial-mesenchymal transition and invasion in colorectal cancer cells
PMCID: Pubmed No.:35083610
CircRNA Circ_0000118 Regulates Malignancy of Cervical Cancer Cells by Regulating miR-211-5p/miR-377-3p/AKT2 Axis
PMCID: Pubmed No.:36719624
Emodin promotes hepatic stellate cell senescence and alleviates liver fibrosis via Nur77-mediated epigenetic regulation of GLS1
PMCID: Pubmed No.:37263753
LINC01088/miR-22/CDC6 Axis Regulates Prostate Cancer Progression by Activating the PI3K/AKT Pathway
PMCID: Pubmed No.:37501932
Blocking peptide available as BD0030P